tiprankstipranks
Trending News
More News >
Hikma Pharma (HKMPY)
:HKMPY
US Market

Hikma Pharmaceuticals (HKMPY) Technical Analysis

Compare
36 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Hikma Pharma’s (HKMPY) Moving Averages Convergence Divergence (MACD) indicator is 0.25, suggesting Hikma Pharma is a Buy.
Hikma Pharma’s (HKMPY) 20-Day exponential moving average is 56.20, while Hikma Pharma’s (HKMPY) share price is $55.48, making it a Sell.
Hikma Pharma’s (HKMPY) 50-Day exponential moving average is 55.01, while Hikma Pharma’s (HKMPY) share price is $55.48, making it a Buy.

Hikma Pharmaceuticals (HKMPY) Pivot Points

Jun 28, 2025, 04:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
56.18
56.18
56.18
56.18
56.18
56.18
56.18
Fibonacci
56.18
56.18
56.18
56.18
56.18
56.18
56.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hikma Pharmaceuticals (HKMPY) Moving Averages

Jun 28, 2025, 04:15 AM
Period
Simple
Exponential
MA5
55.65Sell
55.83Sell
MA10
56.42Sell
56.17Sell
MA20
56.94Sell
56.20Sell
MA50
54.49Buy
55.01Buy
MA100
53.84Buy
53.67Buy
MA200
51.42Buy
51.83Buy
Hikma Pharma’s (HKMPY) 10-Day exponential moving average is 56.17, while Hikma Pharma’s (HKMPY) share price is $55.48, making it a Sell.
Hikma Pharma’s (HKMPY) 100-Day exponential moving average is 53.67, while Hikma Pharma’s (HKMPY) share price is $55.48, making it a Buy.
Hikma Pharma’s (HKMPY) stock price is $55.48 and Hikma Pharma’s (HKMPY) 50-day simple moving average is 54.49, creating a Buy signal.
Hikma Pharma’s (HKMPY) stock price is $55.48 and Hikma Pharma’s (HKMPY) 100-day simple moving average is 53.84, creating a Buy signal.
Hikma Pharma’s (HKMPY) stock price is $55.48 and Hikma Pharma’s (HKMPY) 200-day simple moving average is 51.42, creating a Buy signal.

Hikma Pharmaceuticals (HKMPY) Technical Indicators

Jun 28, 2025, 04:15 AM
Name
Value
Implied Action
RSI (14)
47.06
Neutral
STOCH (9,6)
12.51
Buy
STOCHRSI (14)
12.51
Buy
MACD (12,26)
0.25
Buy
ADX (14)
17.98
Buy
Williams %R
-92.55
Buy
CCI (14)
-124.48
Buy
ATR (14)
0.62
-
Ultimate Oscillator
34.23
Neutral
ROC
-2.72
Sell
Hikma Pharma’s (HKMPY) Relative Strength Index (RSI) is 47.06, creating a Neutral signal.
Hikma Pharma’s (HKMPY) Trend Strength Indicator (ADX) is 17.98, creating a Buy signal.
Hikma Pharma’s (HKMPY) Commodity Channel Index (CCI) is -124.48, creating a Buy signal.
Hikma Pharma’s (HKMPY) Price Rate of Change (ROC) is -2.72, creating a Sell signal.

FAQ

Is HKMPY a Buy, Hold, or Sell?
Based on HKMPY’s technical indicators, HKMPY is a Buy.
    What is HKMPY’s RSI (14)?
    HKMPY’s RSI (14) is 47.06, which suggests HKMPY is a Neutral.
      What is HKMPY’s MACD?
      HKMPY’s MACD is 0.25, which suggests HKMPY is a Buy.
        What is HKMPY’s 5-day moving average?
        HKMPY’s 5-day moving average is 55.65, which suggests HKMPY is a Sell.
          What is HKMPY’s 20-day moving average?
          HKMPY 20-day moving average is 56.94, which suggests HKMPY is a Sell.
            What is HKMPY’s 50-day moving average?
            HKMPY’s 50-day moving average is 54.49, which suggests HKMPY is a Buy.
              What is HKMPY’s 200-day moving average?
              HKMPY’s 200-day moving average is 51.42, which suggests HKMPY is a Buy.
                What is HKMPY’s Williams % R (14)?
                HKMPY’s Williams % R (14) is -92.55, which suggests HKMPY is a Buy.
                  What is HKMPY’s CCI (14)?
                  HKMPY’s CCI (14) is -124.48, which suggests HKMPY is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis